USANA HEALTH SCIENCES INC
For the period ended Nov 3, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 3, 2026 · Filed Nov 3, 2026
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter ended | ||
|---|---|---|
| October 3, 2026 | September 27, 2025 | |
| Net loss attributable to USANA (GAAP) | $(5,556) | $(6,522) |
| Loss per common share - Diluted | $(0.30) | $(0.36) |
| Weighted Average common shares outstanding - Diluted | 18,498 | 18,293 |
| Adjustment to net loss: | ||
| Transaction, integration and transition costs - Hiya | $— | $179 |
| Amortization of intangible assets - Hiya | 4,455 | 4,455 |
| Adjustments to net loss attributable to noncontrolling interest | (942) | (942) |
| Adjusted net loss attributable to USANA | $(2,043) | $(2,830) |
| Adjusted loss per common share - Diluted | $(0.11) | $(0.15) |
| Weighted average common shares outstanding - Diluted | 18,498 | 18,293 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.